ORIGINAL RESEARCH PAPER ON PROSPECTIVE OBSERVATIONAL STUDY FOR RISK OFPOLYPHARMACY PRESCRIPTION PATTERNS AT TERTIARY CARE HOSPITAl
Abstract
Keywords
Full Text:
PDFReferences
.1 Kuhn-Thiel, A. M. Weiss, C., Webling, M., & Faller B. Polypharmacy in older patients: what is it and how can it be measured? Experimental gerontology. 2015:(69):10-9.
.L Hepler, C. D., & Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharmacy. 1990;3(47) 533-43.
.Maher, R. L. Hanlon, J. Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 1(13):57-65.
.Marcum, Z. A., & Hanlon JT. Recognizing the risks of polypharmacy in older adults. Clin Care Aging. 2010.9(18):33-68. [5].Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., & Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. ((10).). [6].Becker, M. L., Kallewaard, M., Caspers, P. W., Visser, L. E., Leufkens, H. G., & Stricker BH. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharm world Sci. 2007;29(4):364-77.
.WM. L. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure.Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology. 2004;40(1):6-9.
.Pasina, L., Djade, C. D., Lucca, U., Nobili, A., Tettamanti, M., Franchi, C. & Mannucci PM. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs & aging. 2013;13(2):103-12
.National institute for health and care excellence. Medicine optimization; the safe and effective use of medicines to enable the best possible outcomes. [internet]. [cited 2023 apr27]. available from :https://www.nice.org.uk/guidance/ng5.
.Richardson, K., Bennett, K., & Kenny RA. Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults. Drugs & aging. 2015;44(1):90-6.
. Kapoor, A., & Kapoor A. Prevalence of polypharmacy among elderly in India: systematic review. J Pharmacol Pharmacother. 2013:4(4):231-6.
. Tripathi, R. K., & Jalgaonkar S V. Prevalence of polypharmacy in a rural population in India: A cross-sectional study. Indian J Community Med. 2015;40(1):33-5
]. Gnjidic, D. Le Couteur, D. G., & Hilmer SN. Underutilisation of pharmacological treatment in older people. Drugs & aging, 2012:29(6):463-75. 8. Maher, R. L., Hanlon, J. T., & Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin drug safety. 2014;13(1):57-65.
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Research & Reviews: A Journal of Pharmacology